Biotech CEO Summit Europe 2020
Now in its fifth year, the Biotech CEO Summit Europe is a private, thought-provoking meeting that brings together European biotech industry leaders in a congenial setting, where they can talk candidly with their peers about the opportunities and challenges facing their organisations and the whole Life Sciences industry.This invitation-only event is limited to 40-50 biotech CEOs who are viewed as thought leaders and influencers in their biotech communities. This year’s event will take place at Coworth Park in Ascot, Berkshire, England, and focus on refining the key skills and enhancing the knowledge base that today’s biotech leaders require to deliver on the promise of transformational science.
Coulter Partners is proud to be a sponsor again in 2020 and CEO, Bianca Coulter, very much looks forward to seeing you in Coworth Park and exchanging ideas with you. She encourages Biotech CEOs to request their personal invitation as soon as possible and reflecting on the fruits of past summits, she says,“This is a fantastic opportunity, not to be missed. The forum is so effective for leaders to share real experiences, learn from one another and evaluate challenges – and how to deal with them – in a genuinely supportive atmosphere.” Request your personal invitation now from Lila Taylor, Chief Business Officer for Demy Colton – firstname.lastname@example.orgFurther information and the full event programme can be found at http://www.biotechceosummit-eu.com/
Held annually in Napa and Europe, the Biotech CEO Summits provide high-value, relationship-building opportunities through informal discussions where personal knowledge, insights, and ideas are exchanged with peers. These candid discussions take place in a secure, confidential setting.
Biotech CEO Summits are limited to CEOs focused on leading their organizations through the ever-evolving biotech landscape, transforming individual companies and the industry as a whole. Non-CEO participants include a select group of industry leaders.
The program includes fireside chats, case studies and group discussions that address a range of global issues key to biotech CEOs and their companies. The Summit format facilitates engagement, discussion and interaction with and between all CEOs. The topics are identified in consultation with the advisory board, and include discussions on strategy (asset selection, collaborations, market approach), financing (public and private), communications to all audiences (shareholders, investors, board of directors, patients, regulatory bodies, and team), human resources (board and team development and management), and lessons learned during make or break situations.